TSTickerStar
Company alerts/PPBT
PPBT company alerts

PPBT updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for PPBT. Subscribe to PPBT alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Official-source feed

Recent PPBT alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

EarningsOfficial company source

Purple Biotech Reports Q3 2026 Results; Net Loss $1.0M on Lower Operating Expenses

Purple Biotech Ltd. reported a net loss of $1.0 million for Q3 2026, compared to a net loss of $1.3 million for Q3 2025, as operating expenses declined. Operating loss decreased to $1.1 million from $1.4 million, driven by lower R&D and G&A spending. The company ended Q3 2026 with $5.1 million in cash and cash equivalents, which management expects to fund operations through late-2027. The company also announced leadership transition with Isaac Israel appointed as Interim CEO following the departure of Gil Efron.

Read source-backed brief